Treatment with fibroblast growth factor 19 increases skeletal muscle fiber size, ameliorates metabolic perturbations and hepatic inflammation in 5/6 nephrectomized mice

Chronic kidney disease (CKD) is associated with osteosarcopenia, and because a physical decline in patients correlates with an increased risk of morbidity, an improvement of the musculoskeletal system is expected to improve morbi-mortality. We recently uncovered that the intestinal hormone Fibroblas...

Descripción completa

Detalles Bibliográficos
Autores principales: Benoit, Berengère, Beau, Alice, Bres, Émilie, Chanon, Stéphanie, Pinteur, Claudie, Vieille-Marchiset, Aurélie, Jalabert, Audrey, Zhang, Hao, Garg, Priyanka, Strigini, Maura, Vico, Laurence, Ruzzin, Jérôme, Vidal, Hubert, Koppe, Laetitia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073190/
https://www.ncbi.nlm.nih.gov/pubmed/37015932
http://dx.doi.org/10.1038/s41598-023-31874-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073190/
https://www.ncbi.nlm.nih.gov/pubmed/37015932
http://dx.doi.org/10.1038/s41598-023-31874-4

Ejemplares similares